A pilot study of AIS patients treated with intravenous thrombolysis (t-PA) revealed that baseline serum AQP4 levels were inversely correlated with infarct size and neurological severity at admission, as measured by the National Institutes of Health Stroke Scale (NIHSS). The gene discussed is AQP4; the disease is Stroke.